Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.1 USD | -0.13% | -1.97% | +3.65% |
May. 08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.65% | 7.09B | |
+4.86% | 109B | |
+11.07% | 105B | |
-0.38% | 22.25B | |
-11.89% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.01% | 16.85B | |
+3.67% | 13.76B | |
+35.85% | 12.46B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Exercises Option for Manufacturing Rights Agreement With Sutro Biopharma